MS41 , CAS No.2768610-97-3

CAS: 2768610-97-3 Cat. No.: M1418397 Formule: C56H70N8O9S Poids moléculaire: 1031.27
DISPONIBLE À COMMANDE
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Taille
USA
Allemagne (EU)*
Prix
Qté
1mg
M1418397-1mg
Sur commande · 8–12 semaines
Enter a quantity for the sizes you want to add.

Vue d’ensemble

MS41 is a selective eleven-nineteen leukemia (ENL) PROTAC degrader, with DC 50 s of 3.50 nM (MV4;11), 2.84 nM (SEMK2), 3.03 nM (Jurkat), and 26.58 nM (KASUMI1), respectively. MS41 effectively inhibits the growth of ENL-dependent leukemia cells, induces G1 cell cycle arrest and increases apoptosis. MS41 reduces the chromatin occupancy of ENL-associated transcription elongation machinery, and suppresses oncogenic gene expression and leukemia progression. Red: ENL ligand. Black: linker. Blue: VHL ligand.

Spécifications

Conditions de stockage de stockage
Store at -20°C
Expédié en
Ice chest + Ice pads
Ce produit nécessite l'expédition en chaîne froide. Les services terrestres et autres services économiques ne sont pas disponibles.
Type d'action
DEGRADER
Noms et identifiants
Poids moléculaire
1031.27

Données avancées

Certificats (CoA, COO, BSE/TSE et tableau d'analyse)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calculateurs de solution
Avis

Avis des clients

Application Protocols

Item-specific validated application protocols are not provided for this product.

General protocols for small-molecule deployment (non-item-specific):

  • Stock preparation: Weigh under low humidity if hygroscopicity is suspected. Prepare a 10–50 mM DMSO stock. Filter through 0.22 µm PTFE if particles persist.
  • Biochemical assays: Add stock to buffer to a final DMSO content of 0.1–2%. Include vehicle controls and, where relevant, detergent (0.01–0.05% Tween 20) to mitigate aggregation artifacts.
  • Cell-based assays: Verify cytotoxicity of vehicle. Titrate compound across 8–12 points (half-log steps). Monitor precipitation/adsorption by visual inspection and LC/MS of media.
  • Analytical QC on receipt: Acquire 1H NMR, LC–MS, and HPLC purity. Reconfirm after >3 months of storage or after freeze–thaw cycles.
  • Documentation: Record lot number, preparation date, solvent, concentration, and storage conditions on all vials and in the ELN.
Biological Roles

Item-specific biological function:

  • Not specified for this item; no target or pathway information is provided in the listing.

General guidance (non-clinical, for research use only):

  • For uncharacterized small molecules, perform preliminary profiling to identify potential liabilities: PAINS/REOS filters, colloidal aggregation assessment (detergent sensitivity), redox activity (HRP-PR assay), fluorescence interference, and metal-chelation potential.
  • Physicochemical triage (if/when structure is available): calculate cLogP, pKa, polar surface area, and rule-of-five metrics to anticipate permeability and nonspecific binding.
  • In vitro stability: Assess chemical stability in assay buffer, microsomal stability if ADME research is planned, and protein binding to estimate free fraction in biochemical assays.
  • Off-target risk mitigation: Employ orthogonal assay formats and counterscreens (e.g., for luciferase inhibition or reporter interference) when interpreting activity data from MS41.
Buffer Applications

This section is typically applicable to buffering agents or salts. MS41 is listed as a small-molecule research compound with no disclosed acid/base characteristics or buffering capacity.

  • Item-specific buffer uses: Not specified for this item; refer to CoA/Spec Sheet.
  • Practical note: If preparing aqueous assay solutions, select buffer systems based on the biological target (e.g., HEPES pH 7.2–7.6, PBS pH ~7.4, Tris pH 7–9). Confirm compound stability across the intended pH range prior to use.
  • To mitigate precipitation upon dilution from DMSO stocks, keep final DMSO at 0.1–2% and pre-equilibrate buffers at working temperature. Add compound to buffer slowly with mixing.
Green Alternatives

Item-specific green profile:

  • Environmental and safety attributes specific to MS41 are not provided. No life-cycle or solvent data are available in the listing.

General recommendations (non-item-specific):

  • Solvent choices dominate the environmental footprint. Favor greener solvents per modern guides (e.g., water, EtOH, i-PrOH, 2-MeTHF, CPME, EtOAc, MeTHF/HOAc systems) where compatible with the compound’s solubility/stability.
  • Minimize DCM/DMF/NMP usage; substitute with EtOAc, i-PrOAc, MeCN, or green amide solvents (e.g., NEP, PolarClean) when feasible.
  • For workup/purification, replace hexanes with heptane or cyclopentyl methyl ether blends; adopt supercritical CO2 for preparative chromatography if available.
  • Implement microscale reactions and high-throughput experimentation to reduce waste generation when scouting conditions for unknown compounds.
  • Energy: Store at the recommended -20°C but avoid unnecessary ultra-cold storage; consolidate shipments to reduce cold-chain impact.

Tradeoffs:

  • Greener solvents may alter reaction rates/selectivity or assay performance. Validate on small scale and document any changes in impurity profile or bioactivity.
Pharmaceutical Uses

No excipient/formulation role or pharmacopeial status is provided for this item.

Scope and constraints:

  • MS41 is supplied strictly for research use only (non-clinical, non-diagnostic). Do not use in humans or for therapeutic applications.

General formulation considerations for small molecules in research (non-item-specific):

  • For in vitro work, prepare concentrated DMSO stocks and dilute into assay buffer while monitoring for precipitation or adsorption losses.
  • For exploratory in vivo research (if permitted by your institution), ensure full characterization of identity, purity, and residual solvents. Develop vehicle systems (e.g., PEG-400/saline, Captisol, or Tween 80/co-solvent blends) only after assessing solubility and stability; obtain appropriate IACUC and safety approvals.
  • Record lot numbers and maintain chain-of-custody and CoA documentation for any regulated studies.
Physical Properties

Item-specific physical data:

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point: Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling point: Not specified for this item; refer to CoA/Spec Sheet.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Not specified for this item; refer to CoA/Spec Sheet.
  • LogP/logD, pKa, refractive index: Not specified for this item; refer to CoA/Spec Sheet.

Practical guidance when properties are unknown (general, not item-specific):

  • Perform a small-scale solubility screen (e.g., DMSO, DMF, MeOH, ACN, EtOH, PBS, water) to establish workable stock solutions for assays. Start at 10 mM in DMSO with gentle warming (<40°C) and sonication.
  • If solid, assess hygroscopicity by mass change after brief ambient exposure; store under inert atmosphere or desiccant if mass gain is observed.
  • If liquid, determine miscibility and volatility qualitatively; cap tightly and minimize headspace.
  • For chromatographic method scouting, begin with reversed-phase LC (C18, 5–95% water–acetonitrile with 0.1% formic or ammonium buffers) and adjust based on retention/ionization.
Quality and Grades

Item-specific quality details:

  • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.

Interpretation and guidance (general):

  • When grade/purity are not listed, confirm via CoA the assay method (e.g., HPLC/UPLC area %, qNMR) and impurity profile (residual solvents, water by KF, inorganic content). Request lot-specific data if necessary for regulated workflows.
  • For screening compounds, typical acceptance is ≥95% by HPLC; for reference standards or SAR-defining tools, ≥98% may be preferred. Verify the analytical method (UV vs ELSD/charged aerosol) to ensure response factors are appropriate.
  • Stabilizers/inhibitors: None are specified for this item. If the compound class is prone to oxidation, hydrolysis, or polymerization, suppliers may add stabilizers; check the CoA explicitly.
  • If low-UV impurities or counterions are relevant (e.g., for LC-UV), request an extended chromatogram and spectral purity to ensure suitability for your assay.
  • Documentation: Retain batch CoA, SDS, and, where applicable, elemental analysis or HRMS confirmation in your ELN to support data integrity.
Reaction and Applications

Item-specific applications from the catalog:

  • Manufacturer Applications: Not specified for this item; refer to catalog updates.

Context and guidance (general, for small-molecule library members):

  • MS41 is listed within a small-molecule/compound library category. Such entries are commonly used as tool compounds or screening hits in phenotypic or target-based assays, orthogonal validation, or SAR benchmarking. Without structural details, treat this as a research chemical pending characterization.
  • If using MS41 as a building block or synthetic intermediate, first establish functional group content via NMR/IR/MS to understand reactivity (e.g., presence of halides, heteroatoms, carbonyls). Pilot reactions at 0.05–0.2 mmol scale are recommended.
  • For bioassay deployment, validate solubility limits, adsorption to plastics, and chemical stability under assay conditions (light, pH, redox, temperature). Employ LC/MS stability-indicating methods.
  • If intended as a positive/negative control, document provenance and analytical purity; cross-check activity with orthogonal readouts to mitigate assay interference (aggregation, redox cycling, fluorescence). Use detergent controls and counter-screens where relevant.
Reaction Conditions

Item-specific reaction condition guidance is not available because the functional groups of MS41 are not disclosed.

General condition-setting guidance (non-item-specific):

  • If halogenated aryl/alkenyl motifs are present: Suzuki–Miyaura (Pd, aqueous base, 25–80°C), Buchwald–Hartwig (Pd, bulky ligands, 60–110°C), Sonogashira (Pd/Cu, amine base, RT–80°C).
  • For carbonyl chemistry: Reductive amination (NaBH3CN or BH(OAc)3, 0–25°C), amide coupling (HATU/EDC or CDI, 0–25°C), hydrazone/oxime formation (pH 4–5, RT).
  • For heteroaromatic N-oxides or activated positions: SNAr in polar aprotic solvents (DMF/DMSO/MeCN, 25–120°C) with alkoxides/amines.
  • Purification: Start with silica gel chromatography (hexanes/EtOAc or DCM/MeOH gradients). If unstable, adopt reversed-phase or avoid acid-activated silica.
  • Always run small pilot reactions to map stability windows before scale-up and document conditions in your ELN.
Safety and Handling

Item-specific hazard information (from Product Data):

  • Signal Word: Not specified for this item; refer to SDS.
  • H-Statements: Not specified for this item; refer to SDS.
  • GHS Classification/Pictograms: Not specified for this item; refer to SDS.

General laboratory precautions (non-item-specific; always defer to SDS):

  • Use in a chemical fume hood. Wear appropriate PPE: lab coat, safety glasses, and chemically resistant gloves (e.g., nitrile). Consider double-gloving for extended handling.
  • Avoid inhalation, ingestion, and skin/eye contact. Wash thoroughly after handling.
  • Storage incompatibilities: Until structure is confirmed, segregate from strong oxidizers, strong acids/bases, and reducing agents. Keep away from ignition sources.
  • First aid (general): If inhaled—move to fresh air; if on skin—wash with soap and water; if in eyes—rinse cautiously with water for several minutes; if ingested—rinse mouth, seek medical attention. Provide the SDS to responders.
  • Spill response: Contain with inert absorbent, collect in labeled waste suitable for incineration. Ventilate area.
  • Waste: Dispose as organic chemical waste in accordance with institutional and regional regulations.

Note: Obtain and review the SDS for MS41 prior to first use; it contains authoritative, item-specific hazards and exposure limits.

Solvent Selection

Item-specific solvent guidance:

  • Solubility/miscibility: Not specified for this item; refer to CoA/Spec Sheet.

General strategy when the structure is undisclosed (non-item-specific):

  • Stock solutions for screening: Start with DMSO (10–50 mM) due to broad solvating power for small molecules. If precipitation occurs upon aqueous dilution, use co-solvents (e.g., 0.5–2% final DMSO, add 5–20% PEG-400 or 1–5% Tween 80 in biochemical assays if compatible).
  • Alternative organic vehicles: DMF and NMP offer high polarity but consider assay toxicity. For LC/MS, acetonitrile and methanol are preferred for volatility and ionization compatibility.
  • For purification: Begin with reversed-phase preparative LC. If the compound is very nonpolar, normal-phase (hexanes/ethyl acetate, toluene/EtOAc, or heptane/MTBE) may be efficient.
  • If salt formation is suspected (amines, acids), evaluate pH-adjusted aqueous buffers to enhance solubility; avoid extreme pH unless stability is confirmed.
  • Always confirm solvent compatibility with downstream biology/analytics and perform a small-scale precipitation test upon aqueous dilution.
Storage and Reconstitution

Item-specific conditions (from Product Data):

  • Storage Conditions: Store at -20°C.
  • Shipped In: Ice chest + Ice pads.

Additional item-specific notes:

  • Appearance and stabilizers: Not specified for this item; refer to CoA/Spec Sheet.
  • Recommended container: Not specified for this item; general guidance below applies.

General handling and reconstitution guidance (non-item-specific):

  • Upon receipt, allow the sealed container to equilibrate to room temperature before opening to minimize condensation ingress. If a solid, store tightly sealed under dry, inert atmosphere or with fresh desiccant. If a liquid, ensure cap integrity and minimize headspace to limit oxidation/volatilization.
  • Reconstitution: If needed, dissolve in a suitable solvent (commonly DMSO for small molecules) to prepare a concentrated stock (e.g., 10–50 mM). Actual solvent choice and achievable concentration are compound-dependent; confirm empirically.
  • Aliquoting: Prepare single-use aliquots to avoid repeated freeze–thaw. Label with concentration, solvent, date, and lot number.
  • Storage of solutions: Prefer -20°C for DMSO stocks unless solubility or stability dictates otherwise. Protect from light if chromophore is suspected. Track stability with periodic LC/MS.
  • Do not use beyond the retest date without re-qualification. Always consult the CoA/SDS for any item-specific storage or stability statements.
Structure and Identity

Item-specific facts (from Product Data):

  • SKU: M1418397
  • Product Name: MS41
  • CAS: 2768610-97-3
  • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.

Notes for users:

  • The structural identity (functional groups, ring systems, stereochemistry) is not provided in the listing. Please consult the Certificate of Analysis (CoA), Spec Sheet, or SDS for definitive identifiers before method development or regulatory documentation.
  • MS41 is cataloged under small molecules/compound libraries; absent more detail, treat as an unidentified small-molecule research reagent.

General guidance (non-item-specific):

  • When structure data are pending, maintain a link between the CAS RN and internal ELN records. Verify spectral identity (NMR/HRMS/UPLC) upon receipt if the compound will be used in screening cascades or SAR.
Synthetic Utility

Item-specific reactivity or functional groups are not disclosed for MS41; therefore, no definitive synthetic roles can be assigned.

General guidance (non-item-specific):

  • If MS41 is intended as a building block, first determine its functional group landscape via spectroscopic analysis (1H/13C NMR, IR, HRMS). Look for handles such as aryl halides (cross-coupling), boronates (Suzuki), alkynes/alkenes (cycloadditions, hydrofunctionalizations), amines/acids (amide coupling), or carbonyls (condensations, reductive aminations).
  • Establish protecting group strategy and chemoselectivity by small-scale test reactions. Assess stability toward acid/base, redox, and heat.
  • For library elaboration, consider late-stage diversification tactics if heteroarenes or C–H activation sites are present; use mild conditions to preserve unknown liabilities.
  • Analytical control: Use UPLC and LC–MS to monitor conversions and impurity growth; store intermediates cold and dry pending further modifications.
Target Specificity

This section applies to biological ligands, antibodies, or characterized tool compounds with known targets. For MS41, no target, binding partner, or specificity information is provided in the Product Data.

  • Item-specific target data: Not specified for this item; refer to CoA/Spec Sheet or associated publications if available.
  • Recommendation: If MS41 is used in target-based assays, record any observed activity, potency, and selectivity in your ELN and validate with orthogonal methods to exclude assay interference.

Foire aux questions

How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 2768610-97-3, the molecular formula is C56H70N8O9S, and the molecular weight is 1031.27 g/mol.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Souhaitez-vous que nous vous envoyions un message lorsque des réductions seront disponibles?

Me rappeler plus tard

Merci ! Veuillez vérifier votre boîte de réception e-mail pour confirmer.

Oups ! Les notifications sont désactivées.